ATE376546T1 - Chinazolinonderivat - Google Patents

Chinazolinonderivat

Info

Publication number
ATE376546T1
ATE376546T1 AT02755797T AT02755797T ATE376546T1 AT E376546 T1 ATE376546 T1 AT E376546T1 AT 02755797 T AT02755797 T AT 02755797T AT 02755797 T AT02755797 T AT 02755797T AT E376546 T1 ATE376546 T1 AT E376546T1
Authority
AT
Austria
Prior art keywords
alkyl group
quinazolinone derivative
onü
äwherein
pollakiuria
Prior art date
Application number
AT02755797T
Other languages
English (en)
Inventor
Masami Muraoka
Kazuki Matsui
Takaaki Yamamoto
Koji Morishita
Masatoshi Yuri
Seiji Katayama
Naohito Ohashi
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE376546T1 publication Critical patent/ATE376546T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02755797T 2001-08-09 2002-08-02 Chinazolinonderivat ATE376546T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001241955 2001-08-09

Publications (1)

Publication Number Publication Date
ATE376546T1 true ATE376546T1 (de) 2007-11-15

Family

ID=19072309

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02755797T ATE376546T1 (de) 2001-08-09 2002-08-02 Chinazolinonderivat

Country Status (13)

Country Link
US (1) US7329665B2 (de)
EP (1) EP1424334B1 (de)
JP (1) JP4087337B2 (de)
KR (1) KR100824506B1 (de)
CN (1) CN1307172C (de)
AT (1) ATE376546T1 (de)
CA (1) CA2457351C (de)
DE (1) DE60223151T2 (de)
DK (1) DK1424334T3 (de)
ES (1) ES2295382T3 (de)
PT (1) PT1424334E (de)
TW (1) TWI308567B (de)
WO (1) WO2003016299A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101945657B (zh) * 2008-02-11 2015-04-22 大日本住友制药株式会社 具有改善的溶出性的片剂
WO2010053068A1 (ja) 2008-11-07 2010-05-14 大日本住友製薬株式会社 新規で有用な下部尿路症状治療剤
KR20180011840A (ko) * 2015-06-12 2018-02-02 비샬 자조디아 스와티 방광 출구 폐쇄 및/또는 하부 요로 증상의 치료에서 사용하기 위한 펜토산폴리설페이트나트륨을 포함하는 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626373B1 (de) * 1993-05-26 1998-12-23 Sumitomo Pharmaceuticals Company, Limited Chinazolinonderivate
EP1122253B1 (de) 1998-10-16 2005-08-17 Sumitomo Pharmaceuticals Company, Limited Quinalozinon-derivate

Also Published As

Publication number Publication date
TWI308567B (de) 2009-04-11
KR20040020081A (ko) 2004-03-06
CN1538966A (zh) 2004-10-20
PT1424334E (pt) 2008-01-10
ES2295382T3 (es) 2008-04-16
KR100824506B1 (ko) 2008-04-22
EP1424334B1 (de) 2007-10-24
DE60223151T2 (de) 2008-08-07
CA2457351A1 (en) 2003-02-27
CN1307172C (zh) 2007-03-28
EP1424334A4 (de) 2005-05-04
EP1424334A1 (de) 2004-06-02
WO2003016299A1 (fr) 2003-02-27
US20050032819A1 (en) 2005-02-10
DK1424334T3 (da) 2008-02-11
JPWO2003016299A1 (ja) 2004-12-02
CA2457351C (en) 2010-01-12
JP4087337B2 (ja) 2008-05-21
DE60223151D1 (de) 2007-12-06
US7329665B2 (en) 2008-02-12

Similar Documents

Publication Publication Date Title
ATE472535T1 (de) Pyrimidinmatrixmetalloproteinaseinhibitoren
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
TW200510441A (en) Novel compounds
WO2003029199A1 (fr) Derives de benzene et procede de preparation et d'utilisation associe
DE60317198D1 (de) Proteinkinaseinhibitoren
HRP20080666T3 (en) Cgrp receptor antagonists
WO2003039461A3 (en) Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
ATE339409T1 (de) Trizyklische verbindungen
NO20071319L (no) Fremgangsmate for fremstilling av isotiazolderivater.
EP1357124A4 (de) Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
DK1031556T3 (da) 2-phenoxyanilinderivater
DE60223151D1 (de) Chinazolinonderivat
CA2366205A1 (en) Biphenyl derivatives
PT1122253E (pt) Derivados de quinazolinona
RS99504A (en) 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
DK0612314T3 (da) 2-pyrazinylethylaminderivater og deres anvendelse som lægemidler
WO2004099130A3 (en) 1,2-diarylimidazoles useful as inhibitors of cox
UY26416A1 (es) Compuestos
WO2002080918A1 (fr) Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
NO20020475D0 (no) 2-aminotetralinderivater for terapi av glaukom
NZ304988A (en) 1-omega-(3,4-dihydro-2-naphthalenyl)alkyl] cyclic amine derivatives and their use
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
EP1650199A4 (de) Sulfonamidderivat mit isoxazolring
DK1282625T3 (da) Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1424334

Country of ref document: EP